Results 161 to 170 of about 89,590 (297)

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

Possibilities of ACE inhibitor therapy in acute myocardial ischemia

open access: yes, 1991
Acute myocardial ischemia results from an increased cardiac workload in presence of a critical coronary stenosis (demand ischemia), coronary occlusion (supply ischemia) or a combination of both.
Kochsiek, K   +6 more
core  

Severe Acute Hypertension Causes Hemolysis With Release of PEP and ACE Inhibitor. [PDF]

open access: yesHypertension
Fischer R   +3 more
europepmc   +1 more source

SARS-CoV-2 induces cardiomyocyte apoptosis and inflammation but can be ameliorated by ACE inhibitor Captopril. [PDF]

open access: yesAntiviral Res, 2023
Huang X   +14 more
europepmc   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Effects of ACE inhibitor and afterload reduction in single ventricles following bidirectional Glenn. [PDF]

open access: yesOpen Heart
Biko DM   +9 more
europepmc   +1 more source

Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci. [PDF]

open access: yesEur Heart J, 2022
Ghouse J   +27 more
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch   +13 more
wiley   +1 more source

ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial. [PDF]

open access: yesPLoS One, 2023
Rossios C   +34 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy